Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infections

8 Jul 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Pneumonia and Respiratory Infections
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 40628957
DOI: 10.1038/s41551-025-01431-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infectionsPMID 40628957Read ↗

Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2Semantic proximity Read ↗

An Update on mRNA-Based Viral VaccinesSemantic proximity Read ↗

A Brief Review on Dna Vaccines in the Era of COVID-19Semantic proximity Read ↗

Nucleic Acid Vaccines against SARS-CoV-2Semantic proximity Read ↗

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious DiseasesSemantic proximity Read ↗

Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease IndicationsSemantic proximity Read ↗

Nucleic acid (DNA) immunization as a platform for dengue vaccine developmentSemantic proximity Read ↗

A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current ApplicationsSemantic proximity Read ↗

Technologies for the design, discovery, formulation and administration of vaccines.Semantic proximity Read ↗

Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector systemSemantic proximity Read ↗

mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2Semantic proximity Read ↗

Delivery of Circular mRNA via Degradable Lipid Nanoparticles against SARS-CoV-2 Delta VariantSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.